Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2021-12-10 00:00:00 ET · period of report 2021-12-08 · accession 0001209191-21-069159 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-10 | 2021-12-08+ | RXRX | Gibson Christopher | CEO, Dir | S - Sale+OE | $20.14 | -11.8K | 23.5K | -33% | -$236.6K |
| D | 2021-12-10 | 2021-12-08 | RXRX | Gibson Christopher | CEO, Dir | M - OptEx | $2.47 | +28.6K | 28.6K | New | +$70.8K |
| DM | 2021-12-10 | 2021-12-08+ | RXRX | Gibson Christopher | CEO, Dir | C - Cnv Deriv | $0.00 | +6,574 | 29.0K | +29% | $0 |
| D | 2021-12-10 | 2021-12-08 | RXRX | Gibson Christopher | CEO, Dir | M - OptEx | $0.00 | -28.6K | 1.47M | -2% | $0 |
| DM | 2021-12-10 | 2021-12-08+ | RXRX | Gibson Christopher | CEO, Dir | C - Cnv Deriv | $0.00 | -6,574 | 8.20M | -0.1% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2021-12-09 | S | D | 1,086 | $20.01 | 23,470 | D | — | — | (F5) This transaction was executed in multiple trades at prices ranging from $20.00 to $20.065. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 2 | Common | Class A Common Stock | 2021-12-08 | M | A | 28,646 | $2.47 | 28,646 | D | — | — | |
| 3 | Common | Class A Common Stock | 2021-12-08 | S | D | 5,176 | $20.03 | 23,470 | D | — | — | (F2) This transaction, representing a sale to cover the exercise price and related tax withholdings for 28,646 option shares, was executed in multiple trades at prices ranging from $20.014 to $20.21. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 4 | Common | Class A Common Stock | 2021-12-09 | C | A | 1,086 | $0.00 | 24,556 | D | — | — | |
| 5 | Common | Class A Common Stock | 2021-12-08 | S | D | 5,488 | $20.26 | 23,470 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $20.00 to $20.57. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 6 | Common | Class A Common Stock | 2021-12-08 | C | A | 5,488 | $0.00 | 28,958 | D | — | — | |
| 7 | Derivative | Stock Option (Right to Buy) | 2021-12-08 | M | D | 28,646 | $0.00 | 1,471,354 | D | $2.47 · — to 2030-12-30 | 28,646 Class A Common Stock | (F6) The option, originally for 1,500,000 shares, of which 28,646 shares have been exercised, vested as to one forty-eighth (1/48th) of the shares subject to the option on January 31, 2021, and one forty-eighth (1/48th) of the shares subject to the option shall vest each month thereafter. |
| 8 | Derivative | Class B Common Stock | 2021-12-09 | C | D | 1,086 | $0.00 | 8,194,642 | D | $0.00 · — to — | 1,086 Class A Common Stock | (F9) Shares of Class B Common Stock held directly and indirectly by the Reporting Person were previously reported in Table I of Forms 4 filed by the Reporting Person. Commencing with this Form 4, shares of Class B Common Stock held directly and indirectly by the Reporting Person are to be reported in Table II of Form 4. (F8) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. |
| 9 | Derivative | Class B Common Stock | 2021-12-08 | C | D | 5,488 | $0.00 | 8,195,728 | D | $0.00 · — to — | 5,488 Class A Common Stock | (F9) Shares of Class B Common Stock held directly and indirectly by the Reporting Person were previously reported in Table I of Forms 4 filed by the Reporting Person. Commencing with this Form 4, shares of Class B Common Stock held directly and indirectly by the Reporting Person are to be reported in Table II of Form 4. (F8) Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. |